The Obama administration Thursday announced a partnership with the industry in which WellPoint Inc., UnitedHealth Group Inc. and other insurers may try to share more billing data with the government to root out fraud.
NoviaCare Clinics LLC will open a multi-employer health clinic in downtown Indianapolis this fall, opening the door for smaller employers to add the service to their health benefits.
Cook Medical Inc. had been planning to open five new manufacturing plants over the next five years in small communities around the Midwest, including Indiana, but has shelved those plans because of the hit it will take from a new U.S. tax on medical devices.
Investors reacted negatively Thursday after medical equipment and hospital bed maker Hill-Rom Holdings Inc. on Wednesday said it was acquiring Aspen Surgical Products for $400 million.
Eli Lilly and Co. reported second-quarter profit that fell less than analysts had expected. The company raised its outlook for the rest of the year.
Bapineuzumab is in a race with a similar product from Indianapolis-based Eli Lilly and Co. to become the first therapy to target a cause for Alzheimer’s, rather than just its symptoms.
Only 1 percent of the jobs given to Texas-based Merritt Hawkins over the past year were for solo practitioners, the physician recruiting firm reported this month. That’s down from 22 percent of all searches in 2004.
A little extra Medicare money will flow to suburban hospitals in the Indianapolis area, based on recent patient satisfaction scores. But hospitals in the core of Indianapolis—and hospitals that do significant amounts of teaching medical students—may take a hit.
Hospital system’s health insurance unit has IT infrastructure that will allow physicians to participate in Medicare’s shared savings program.
MaxIT’s 1,300 employees, who provide information technology services to hospitals and physician practices, will join Virginia-based Science Applications International Corp.
For the first time, Indiana University Health has been named to U.S. News & World Report's "Best Hospitals Honor Roll," a distinction that goes to the top medical centers in the country.
WellPoint Inc. said it will pay for DNA testing for three children to see if they have an inherited heart disease their father suffers from that often strikes without warning, reversing an earlier decision to deny coverage.
Eli Lilly and Co. said a potential treatment for acute schizophrenia failed in a late-stage study that compared patients taking the drug to those taking a placebo.
Johnson & Johnson, Pfizer Inc. and Elan Corp are racing Indianapolis-based Eli Lilly and Co. to market the first broadly available drug designed to target a cause of Alzheimer’s, rather than just its symptoms. Analysts say the potential drugs are long shots.
A chain of dental offices that abruptly closed multiple Indiana locations in December 2010 left patients without care, refunds or records, according to a complaint filed by the Office of the Indiana Attorney General.
Indiana University Health, as well as a partnership of Franciscan Alliance and American Health Network, have formed accountable care organizations that won the blessing of the federal Medicare Shared Savings program.
Eli Lilly and Co. said Friday that it has received an extra six months of marketing exclusivity on the antidepressant Cymbalta, its biggest selling drug. The extension could mean more than a billion dollars in sales for the Indianapolis drug maker.
When Helene Cross arrived to lead Fairbanks Addiction Treatment Center in 2001, the alcohol and drug rehabilitation hospital was as sick financially as its patients were physically.
The great results Regenstrief Institute has produced over the years in studies at Indianapolis’ Wishard Memorial Hospital have not held up when conducted in a wider variety of settings.
Bristol-Myers Squibb Co. has agreed to pay $5.3 billion to acquire former Eli Lilly and Co. partner Amylin Pharmaceuticals Inc., a maker of diabetes therapies. The deal is valued at about $7 billion, which includes Amylin’s debt and a payment to Eli Lilly and Co. of about $1.7 billion.
